Thus, as long as safe and efficient pharmacological anti-obesity compounds continue being developed, a probiotic with natural α-MSH mimetic properties may become an option for obesity and overweight prevention or treatment. The gene discussed is STAMBP; the disease is obesity due to melanocortin 4 receptor deficiency.